Global Hematology Market is slated to see a CAGR of 3% to 5% by 2027 - Transforming the Market of Patient Care

Hematology is a segment of medicine related to the monitoring of blood and blood-forming organs. It covers a broad spectrum of benign and malignant diseases and medical conditions of the red and white blood cells, platelets and the coagulation system in older people and kids. The specialists in hematology research, diagnose and treat various medical disorders such as anemia, bleeding disorders such as hemophilia, blood clots, sickle cell disease and blood cancers such as leukemia, lymphoma, and myeloma.

Impact of Covid-19 Pandemic on the Hematology Market

Covid-19 had positively affected the hematology market as there was a growing focus on hematology parameters for the examination of Covid-19. Covid-19 boosted the demand for hematology analyzers which were used to run various body tests such as blood levels, blood counts, and analysis of the blood sample. Lungs were the most impacted organ by Co-vid 19 virus. A hematology test is necessary to examine the lungs and the RBCs count.

Technological Innovations in Hematology Analyzers Drives the Growth of the Global Hematology Market

The global hematology market has been marked by consistent technological innovations, which is further triggering the growth of the hematology market.

For instance,

  • In May 2023, Siemens Healthineers had launched next-gen hematology analyzers for high-volume hematology testing, the Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer. Both these analyzers provide intuitive interfaces and multi-analyzer automation connectivity to decrease the workflow roadblocks.

AI-Powered Automatic Hematology Analyzers Projected to Advance the Diagnostic Capabilities of Laboratories

For examining the hematological diseases, most of the hematology analyzers offer only basic data. As the volume of data produced by hematology analyzers increases, clinicians and doctors are overloaded with large volume of data and they face problems in monitoring the important data. Adoption of AI-powered automatic hematology analyzers applies artificial intelligence analysis to produce interpretable data which helps to reduce turn-around time, decrease technical misclassifications and decrease the workload of doctors and clinicians. 

“Rising cases of blood disorders, technological developments in hematology analyzers, and digital transformation of hematology laboratories globally are some of the major factors triggering the growth of the hematology market. Approximately, 80 million patients alone are affected with blood disorders in EU.”-Director, Manufacturer of Hematology Analyzers, USA

Competitive Landscape Analysis: Global Hematology Market

The global hematology market is marked by the presence of some of the leading and emerging market players such as Sysmex Corporation, Beckman Coulter/Danaher Corporation, Siemens Healthineers, Abbott, Mindray, Nihon Kohden, Boule Diagnostics, Bio-Rad Laboratories, Horiba, Drew Scientific.

Aggressive Growth Strategies Adopted by the Key Market Players to Establish Their Foothold in the Global Hematology Market

All the top players operating in the global hematology market have adopted aggressive growth strategies such as new product launches, partnerships, acquisitions to gain a higher market share.

For instance,

  • In July 2022, Beckman Coulter and Scopio Labs partnered to increase the adoption of hematology digital cell morphology platform.

The outlook of the global hematology market looks good due to the technological innovations in hematology analyzers, rising demand for laboratory automation to enhance precision and efficiency, an increasing cases of blood disorders and adoption of aggressive growth strategies by the market players.

Get Detailed Insights on Hematology Market with a FREE Sample Report @ https://meditechinsights.com/global-hematology-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more